DBV Technologies Logs Wider Loss, Has Doubts on Continuing as Going Concern

Dow Jones

Jul 30

By Kelly Cloonan

DBV Technologies logged a wider loss in its second quarter and said it has doubts it can continue as a going concern.

The biopharmaceutical company on Tuesday posted a loss of $41.9 million, or 31 cents a share, compared with a loss of $33.1 million, or 34 cents a share, a year earlier.

Analysts polled by FactSet expected a loss per share of 18 cents.

DBV also said there is substantial doubt regarding its ability to continue as a going concern.

It estimates that its cash and cash equivalents are sufficient to fund its operations into the second quarter of 2026, given it received gross proceeds of $125.5 million on April 7 related to financing for its Viaskin Peanut patch.

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

July 29, 2025 17:41 ET (21:41 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2555627450"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2555627450\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2555627450?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-30 05:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2555627450","market":"us","top_or_hot":-1,"title":"DBV Technologies Logs Wider Loss, Has Doubts on Continuing as Going Concern","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By <a href=\"https://laohu8.com/S/KELYA\">Kelly</a> Cloonan \n</p>\n<pre>\n \n</pre>\n<p>\n  DBV Technologies logged a wider loss in its second quarter and said it has doubts it can continue as a going concern. \n</p>\n<p>\n  The biopharmaceutical company on Tuesday posted a loss of $41.9 million, or 31 cents a share, compared with a loss of $33.1 million, or 34 cents a share, a year earlier. \n</p>\n<p>\n  Analysts polled by FactSet expected a loss per share of 18 cents. \n</p>\n<p>\n  DBV also said there is substantial doubt regarding its ability to continue as a going concern. \n</p>\n<p>\n  It estimates that its cash and cash equivalents are sufficient to fund its operations into the second quarter of 2026, given it received gross proceeds of $125.5 million on April 7 related to financing for its Viaskin Peanut patch. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to <a href=\"https://laohu8.com/S/KELYB\">Kelly</a> Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 29, 2025 17:41 ET (21:41 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DBV Technologies Logs Wider Loss, Has Doubts on Continuing as Going Concern</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDBV Technologies Logs Wider Loss, Has Doubts on Continuing as Going Concern\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-30 05:41</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By <a href=\"https://laohu8.com/S/KELYA\">Kelly</a> Cloonan \n</p>\n<pre>\n \n</pre>\n<p>\n  DBV Technologies logged a wider loss in its second quarter and said it has doubts it can continue as a going concern. \n</p>\n<p>\n  The biopharmaceutical company on Tuesday posted a loss of $41.9 million, or 31 cents a share, compared with a loss of $33.1 million, or 34 cents a share, a year earlier. \n</p>\n<p>\n  Analysts polled by FactSet expected a loss per share of 18 cents. \n</p>\n<p>\n  DBV also said there is substantial doubt regarding its ability to continue as a going concern. \n</p>\n<p>\n  It estimates that its cash and cash equivalents are sufficient to fund its operations into the second quarter of 2026, given it received gross proceeds of $125.5 million on April 7 related to financing for its Viaskin Peanut patch. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to <a href=\"https://laohu8.com/S/KELYB\">Kelly</a> Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 29, 2025 17:41 ET (21:41 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DBVT","symbol_name":"DBV Technologies S.A.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2555627450","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2555627450","pubTimestamp":1753825260,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"DBV Technologies logged a wider loss in its second quarter and said it has doubts it can continue as a going concern.The biopharmaceutical company on Tuesday posted a loss of $41.9 million, or 31 cents a share, compared with a loss of $33.1 million, or 34 cents a share, a year earlier.Analysts polled by FactSet expected a loss per share of 18 cents.DBV also said there is substantial doubt regarding its ability to continue as a going concern.It estimates that its cash and cash equivalents are sufficient to fund its operations into the second quarter of 2026, given it received gross proceeds of $125.5 million on April 7 related to financing for its Viaskin Peanut patch.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DBVT":"DBV Technologies S.A.","DBV":"Invesco DB G10 Currency Harvest Fund","BK4139":"生物科技"},"translate_title":"DBV Technologies亏损扩大，对持续经营存疑","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DBV":1,"DBVT":0.9},"content_text":"By Kelly Cloonan \n\n\n \n\n\n  DBV Technologies logged a wider loss in its second quarter and said it has doubts it can continue as a going concern. \n\n\n  The biopharmaceutical company on Tuesday posted a loss of $41.9 million, or 31 cents a share, compared with a loss of $33.1 million, or 34 cents a share, a year earlier. \n\n\n  Analysts polled by FactSet expected a loss per share of 18 cents. \n\n\n  DBV also said there is substantial doubt regarding its ability to continue as a going concern. \n\n\n  It estimates that its cash and cash equivalents are sufficient to fund its operations into the second quarter of 2026, given it received gross proceeds of $125.5 million on April 7 related to financing for its Viaskin Peanut patch. \n\n\n \n\n\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 29, 2025 17:41 ET (21:41 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}